Pharmalot Ed Silverman Pharmalot, Pharmalittle: Alnylam stock plunges after key clinical trial is ended
Pharmalot Ed Silverman Pharmalot, Pharmalittle: US drug prices are highest, UnitedHealth favors Regeneron
